CWM, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
CWM, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$250.0%3,531
+0.5%
0.00%
Q2 2023$25
-16.7%
3,513
-1.2%
0.00%
Q1 2023$30
-28.6%
3,555
-2.0%
0.00%
Q4 2022$42
-99.9%
3,628
+6.3%
0.00%
Q3 2022$43,000
+19.4%
3,4130.0%0.00%
Q2 2022$36,000
-34.5%
3,4130.0%0.00%
Q1 2022$55,000
+17.0%
3,4130.0%0.00%
Q4 2021$47,000
-13.0%
3,4130.0%0.00%
Q2 2021$54,0000.0%3,4130.0%0.00%
Q1 2021$54,0000.0%3,4130.0%0.00%
Q4 2020$54,0000.0%3,4130.0%0.00%
Q3 2020$54,0000.0%3,4130.0%0.00%
Q2 2020$54,0000.0%3,4130.0%0.00%
Q1 2020$54,0000.0%3,4130.0%0.00%
Q4 2019$54,0000.0%3,4130.0%0.00%
Q3 2019$54,0000.0%3,4130.0%0.00%
Q2 2019$54,0000.0%3,4130.0%0.00%
Q1 2019$54,0003,4130.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders